2-Chloro-3-fluoro-4-iodo-1-methoxybenzene, 98%, 1g

4-(4-Aminophenyl)piperazine-1-carboxylic acid tert-butyl ester, 98.00%, 10g

(+/-)-Phenyl(pyridin-2-yl)methanol>98.0%(GC)1g

Uniconazole>98.0%(HPLC)(T)5g

Closing caps, Gesch. front, Ø 25 mm 500 pcs

1-Bromo-2,3,5-trifluorobenzene, 98.0%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4,4-difluorocyclohexyl)propanoic acid, 98%, 100mg

(3R,4S)-1-(tert-Butoxycarbonyl)-4-(3-cyanophenyl)pyrrolidine-3-carboxylic acid, 95.0%, 250mg

2-BROMO-7-METHYLH-IMIDAZO[1,2-A]PYRIDINE, 95.0%, 250mg

4-Nitro-m-cresol>98.0%(GC)(T)500g

N4-(3-Chloro-4-fluorophenyl)-7-methoxyquinazoline-4,6-diamine, 97.0%, 25g

(2S)-2-AMINO-3-(4-FLUOROPHENYL)PROPAN-1-OL, 95.0%, 250mg

Dicyclohexylamine (R)-2-(((benzyloxy)carbonyl)amino)-4-((tert-butoxycarbonyl)amino)butanoate, 97%, 5g